 |
|
|
| |
48 Week Study of Tenofovir Alafenamide (TAF) vs. Tenofovir Disoproxil Fumarate (TDF), Each in a Single Tablet Regimen (STR) with Elvitegravir, Cobicistat, and Emtricitabine
[E/C/F/TAF vs. E/C/F/TDF] for Initial HIV Treatment
|
| |
| |
Reported by Jules Levin
53rd ICAAC, Denver, CO
September 10-13, 2013
P. Sax1, I. Brar2, R. Elion3, A. Zolopa4, R. Ortiz5, H Wang6, C Callebaut6, H Martin6, M Fordyce6,
S. McCallister6
1Brigham and Women's Hosp, Boston MA, US; 2Henry Ford Hosp, Detroit MI, US; 3George Washington
Univ. Hosp, Washington DC, US; 4Stanford Univ, Palo Alto CA, US;
5Orlando Immunology Ctr, Orlando, FL, US; 6Gilead Sciences, Foster City CA, US
|
| |
|
|
|
|
|
